BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21620938)

  • 21. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
    Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
    Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
    Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
    Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designing HPMC matrices with improved resistance to dissolved sugar.
    Williams HD; Ward R; Culy A; Hardy IJ; Melia CD
    Int J Pharm; 2010 Nov; 401(1-2):51-9. PubMed ID: 20858538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of citric acid added to hydroxypropyl methylcellulose (HPMC) matrix tablets on the release profile of vinpocetine.
    Nie S; Pan W; Li X; Wu X
    Drug Dev Ind Pharm; 2004 Jul; 30(6):627-35. PubMed ID: 15285336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric floating matrix tablets: design and optimization using combination of polymers.
    Prajapati ST; Patel LD; Patel DM
    Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of drug solubility on the release of slightly water-soluble drugs from HPMC matrices.
    Fu XC; Liang WQ; Wang GP
    Pharmazie; 2003 May; 58(5):355-6. PubMed ID: 12779057
    [No Abstract]   [Full Text] [Related]  

  • 27. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices.
    Levina M; Rajabi-Siahboomi AR
    J Pharm Sci; 2004 Nov; 93(11):2746-54. PubMed ID: 15389670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting drug release from HPMC/lactose tablets.
    Siepmann J; Karrout Y; Gehrke M; Penz FK; Siepmann F
    Int J Pharm; 2013 Jan; 441(1-2):826-34. PubMed ID: 23262427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
    Gohel MC; Amin AF; Patel KV; Panchal MK
    Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
    Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
    Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer.
    Ju RT; Nixon PR; Patel MV
    J Pharm Sci; 1995 Dec; 84(12):1455-63. PubMed ID: 8748329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro simulation of drug intestinal absorption.
    Lamberti G; Cascone S; Iannaccone M; Titomanlio G
    Int J Pharm; 2012 Dec; 439(1-2):165-8. PubMed ID: 23078860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct measurement of the time-dependent mechanical response of HPMC and PEO compacts during swelling.
    Hewlett KO; L'Hote-Gaston J; Radler M; Shull KR
    Int J Pharm; 2012 Sep; 434(1-2):494-501. PubMed ID: 22609126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between the release of soluble drugs from HPMC matrices and the physicochemical properties of drugs.
    Fu XC; Liang WQ; Ma WX
    Pharmazie; 2003 Mar; 58(3):221-2. PubMed ID: 12685821
    [No Abstract]   [Full Text] [Related]  

  • 37. Parametric simulation of drug release from hydrogel-based matrices.
    Lamberti G
    J Pharm Pharmacol; 2012 Jan; 64(1):48-51. PubMed ID: 22150671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The power law can describe the 'entire' drug release curve from HPMC-based matrix tablets: a hypothesis.
    Rinaki E; Valsami G; Macheras P
    Int J Pharm; 2003 Apr; 255(1-2):199-207. PubMed ID: 12672615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and evaluation of extended release asymmetric membrane capsules of atenolol.
    Guarve K; Gupta GD
    Curr Drug Deliv; 2011 Mar; 8(2):159-63. PubMed ID: 21235475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the behavior of HPMC/Theophylline matrices for controlled drug delivery.
    Barba AA; d'Amore M; Cascone S; Chirico S; Lamberti G; Titomanlio G
    J Pharm Sci; 2009 Nov; 98(11):4100-10. PubMed ID: 19226633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.